Trial NCT00206063

View at ClinicalTrials.gov 
Org. Study IDs: SH-TPA-0004
Secondary IDs: D4004C00004

Last trial update was posted on 2010-11-15

MeSH Interventions

Ximelagatran

MeSH Conditions

Atrial Fibrillation

Other Conditions

Stroke Prevention in Patients With Atrial Fibrillation

Stopping Reasons

Melagatran/ximelagatran was withdrawn from the market and clinical development in February 2006 in the interest of patient safety.

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID